Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Angle BioPharma
Beijing, Beijing, Chinaanglebiopharma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Angle BioPharma is a clinical-stage biotechnology company headquartered in Beijing, China, dedicated to the development of next-generation cancer immunotherapies. The company leverages three core technology platforms: oncolytic herpes simplex virus (oHSV), mRNA-based therapeutics, and advanced cell therapies. Its lead product candidate, AG-01, is a genetically engineered oncolytic virus (oHSV-1) that expresses Granulocyte-macrophage colony-stimulating factor (GM-CSF) to induce a potent anti-tumor immune response. AG-01 is currently being evaluated in Phase 2 clinical trials for various advanced solid tumors. Angle BioPharma's integrated approach combines viral vector engineering with nucleic acid delivery to address complex challenges in oncology. The company operates its own GMP-compliant manufacturing facilities to support its clinical pipeline and future commercialization efforts.
- Therapeutic areas
- Oncology
- Modalities
- Oncolytic virus therapymRNA-based drugsCell therapy
- Industry
- Biotech
Beyond the preview
Go deeper on Angle BioPharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Angle BioPharma.